Corp-Ethics Home
Log In | Register New User
Home Company Search Related Articles Forum (new!)

Company GlaxoSmithKline [Company Info]
  Track this Company (an email will be sent to you everytime a report is filed about this company)

Date Issue Title
29th Mar 2006 Questionable Practice Glaxo agrees US Paxil settlement

Report
GlaxoSmithKline (GSK) has agreed to pay $14m (8m) to settle US claims that it fraudulently tried to delay competitors to anti-depressant drug Paxil.

It agreed the deal with Eliot Spitzer, New York Attorney General, who brought the case on behalf of 49 states.

GSK was accused of using frivolous patent-infringement lawsuits against generic producers of Paxil, keeping the drug's cost higher than necessary.

In reaching the deal, GSK said it denied any wrongdoing or liability.

"We made the decision that settling was appropriate to avoid the expense and distraction of protracted litigation," a company spokeswoman said.

The settlement will cover the cost of drug purchases by Medicaid, the state and federally funded medical programme for low income patients.

"GSK used the courts to hold onto a monopoly for a popular drug and the end result was that consumers - including Medicaid - paid more than they should have," said Jay Nixon, Missouri Attorney General, in a statement.

The company reached a separate deal with Mr Spitzer in 2004 to settle claims that it withheld negative information about Paxil, which is marketed as Seroxat in many markets.

As part of the agreement, it agreed to publish results of clinical trials of new drugs.

Other Reports on GlaxoSmithKline
Date Issue Company Report
29th Jan 2007 Questionable Practice GlaxoSmithKline GSK hid paxil suicide link
10th Aug 2006 Other Issue GlaxoSmithKline Glaxo pays $70m to end price row
18th Mar 2005 Other Issue GlaxoSmithKline Glaxo shares dip on factory probe
22nd Sep 2004 Questionable Practice GlaxoSmithKline Glaxo drops appeal in Aids drug pricing case
6th Sep 2004 Other Issue GlaxoSmithKline GSK faces anti-depressant lawsuit
19th May 2004 Other Issue GlaxoSmithKline New York sues GlaxoSmithKline
11th May 2004 Fraud Investigation GlaxoSmithKline GlaxoSmithKline faces antitrust investigation
22nd Jan 2004 Fraud Investigation GlaxoSmithKline $11.1 Million settlement
8th Jan 2004 Questionable Practice GlaxoSmithKline 1.5bn Tax Bill
16th Dec 2003 Questionable Practice GlaxoSmithKline Glaxo's CEO to scoop 5.7 mln stg a year
25th Jun 2003 Questionable Practice GlaxoSmithKline FDA tells Glaxo to pull misleading Flonase ads
25th Jun 2003 Questionable Practice GlaxoSmithKline Ordered to pull misleading adverts

Related Reports from the Pharamaceutical Industry
Company Issue Report
Bayer Fraud Investigation $11.1 Million settlement
AstraZeneca Fraud Investigation Fined for Medicaid Fraud
Pfizer Questionable Practice Pfizer claims Britons denied treatment
Pfizer Questionable Practice Pfizer to use DART for online campaigns
AstraZeneca Fraud Investigation $355m fraud fine
 
Contact Us | Terms of Service | Privacy Policy | Add Report | Links
© 2006 Corp-Ethics.com | Corporate Ethics